4.7 Article

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations

Gregory M. Laird et al.

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Biochemistry & Molecular Biology

Visualization of Positive Transcription Elongation Factor b (P-TEFb) Activation in Living Cells

Koh Fujinaga et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition

Yujie Tang et al.

NATURE MEDICINE (2014)

Article Biochemistry & Molecular Biology

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo

C. Korin Bullen et al.

NATURE MEDICINE (2014)

Article Biochemistry & Molecular Biology

HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters

Sebastian Eilebrecht et al.

NUCLEIC ACIDS RESEARCH (2014)

Review Plant Sciences

Marine natural products: Bryostatins in preclinical and clinical studies

Peter Kollar et al.

PHARMACEUTICAL BIOLOGY (2014)

Article Multidisciplinary Sciences

Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

Anthony R. Cillo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Multidisciplinary Sciences

Screening for noise in gene expression identifies drug synergies

Roy D. Dar et al.

SCIENCE (2014)

Article Virology

Reactivation of latent HIV-1 by new semi-synthetic ingenol esters

Diego Pandelo Jose et al.

VIROLOGY (2014)

Review Virology

HIV-1 Latency in Monocytes/Macrophages

Amit Kumar et al.

VIRUSES-BASEL (2014)

Article Biochemistry & Molecular Biology

The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation

Zichong Li et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

CTIP2 is a negative regulator of P-TEFb

Thomas Cherrier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Virology

HIV-1 transcription and latency: an update

Carine Van Lint et al.

RETROVIROLOGY (2013)

Article Biochemistry & Molecular Biology

Small-Molecule Inhibition of BRDT for Male Contraception

Martin M. Matzuk et al.

Article Cell Biology

BET bromodomain inhibition as a novel strategy for reactivation of HIV-1

Camellia Banerjee et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2012)

Article Biochemistry & Molecular Biology

PKC phosphorylates HEXIM1 and regulates P-TEFb activity

Koh Fujinaga et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Cell Biology

Reactivation of Latent HIV-1 by Inhibition of BRD4

Jian Zhu et al.

CELL REPORTS (2012)

Article Medicine, Research & Experimental

Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression

Jonathan Karn et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Review Virology

Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs

Lisa N. McKernan et al.

ADVANCES IN VIROLOGY (2012)

Article Biochemistry & Molecular Biology

HIV-1 Replication and Latency Are Regulated by Translational Control of Cyclin T1

Mainul Hoque et al.

JOURNAL OF MOLECULAR BIOLOGY (2011)

Review Virology

Host hindrance to HIV-1 replication in monocytes and macrophages

Anna Bergamaschi et al.

RETROVIROLOGY (2010)

Review Biochemistry & Molecular Biology

A pervasive role of histone acetyltransferases and deacetylases in an NF-κB-signaling code

Miriam Calao et al.

TRENDS IN BIOCHEMICAL SCIENCES (2008)

Article Biochemistry & Molecular Biology

Prostratin antagonizes HIV latency by activating NF-κB

SA Williams et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Medicine, General & Internal

Combination antiretroviral therapy and the risk of myocardial infarction

N Friis-Moller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Immunology

HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class 1

O Kutsch et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)